# The GATE Trial: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device

> **NCT05711043** · NA · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 58 (estimated)

## Conditions studied

- Diabetes Mellitus Type 2 in Obese

## Interventions

- **DEVICE:** Endoscopic sutured gastroplasty with endomina

## Key facts

- **NCT ID:** NCT05711043
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2023-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05711043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05711043, "The GATE Trial: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05711043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*